Life Science Investing Delcath Systems Announces Investigator-Initiated CHOPIN Phase 2 Trial Presentation at ESMO 2025 Congress
Life Science Investing Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635
Life Science Investing Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Colorectal Cancer
Providence Gold Mines: Unlocking Untapped, High-grade Gold Deposits in the historic Mother Lode Gold Belt in California